Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label rollover study for subjects discontinuing from UK-453,061 HIV-1 protocols
2008-006049-26Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lersivirine in Human immunodeficiency virus infection type 1, sponsored by Pfizer. Primary endpoint: Safety assessed by adverse events. Started Jan 2009; status: terminated.
02
Drugs
lersivirine
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2008-006049-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006049-26.